Jette Sønderskov Gørløv

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2016 · 582 citations · Full text

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 364 citations · Full text

Neuro-oncology, Radiation Oncology, Lymphoid Neoplasia +12

The Danish National Lymphoma Registry: Coverage and Data Quality

Bente Arboe, Tarec Christoffer El‐Galaly, Michael Roost Clausen et al. · PLoS ONE · 2016 · 111 citations · Full text

Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers

Mette Skovgaard Christensen, Jesper Medom Vestergaard, Francesco d’Amore et al. · Epidemiology · 2018 · 45 citations

Low‐molecular‐weight carbohydrate Pentaisomaltose may replace dimethyl sulfoxide as a safer cryoprotectant for cryopreservation of peripheral blood stem cells

Jesper Dyrendom Svalgaard, Eva Haastrup, Kristian Reckzeh et al. · Transfusion · 2016 · 25 citations · Full text